CVS HEALTH CORPORATION Current Income Tax Expense (Benefit)
CVS HEALTH CORPORATION (CVS) reported Current Income Tax Expense (Benefit) of $306.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-10
- CVS HEALTH CORPORATION current income tax expense (benefit) for fiscal 2025 was $306.00M, a 85.66% decline from fiscal 2024.
- CVS HEALTH CORPORATION current income tax expense (benefit) for fiscal 2024 was $2.13B, a 38.70% decline from fiscal 2023.
- CVS HEALTH CORPORATION current income tax expense (benefit) for fiscal 2023 was $3.48B, a 1.61% decline from fiscal 2022.
- CVS HEALTH CORPORATION current income tax expense (benefit) for fiscal 2022 was $3.54B, a 19.93% increase from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $306.00M 10-K · filed 2026-02-10 | |
| 2024-12-31 | $2.13B 10-K · filed 2026-02-10 | |
| 2023-12-31 | $3.48B 10-K · filed 2026-02-10 | |
| 2022-12-31 | $3.54B 10-K · filed 2025-02-12 | |
| 2021-12-31 | $2.95B 10-K · filed 2024-02-07 | |
| 2020-12-31 | $3.13B 8-K · filed 2023-05-25 | |
| 2019-12-31 | $3.02B 10-K · filed 2022-02-09 | |
| 2018-12-31 | $1.98B 10-K · filed 2021-02-16 | |
| 2017-12-31 | $3.06B 10-K · filed 2020-02-18 | |
| 2016-12-31 | $3.31B 8-K · filed 2019-08-08 | |
| 2015-12-31 | $3.62B 10-K · filed 2018-02-14 | |
| 2014-12-31 | $3.08B 10-K · filed 2017-02-09 | |
| 2013-12-31 | $3.06B 10-K · filed 2016-02-09 | |
| 2012-12-31 | $2.64B 10-K · filed 2015-02-10 | |
| 2011-12-31 | $2.15B 10-K · filed 2014-02-11 | |
| 2010-12-31 | $2.23B 10-K · filed 2013-02-15 | $2.24B 10-K · filed 2011-02-18 |
| 2009-12-31 | $2.16B 10-K · filed 2012-02-17 | $2.16B 10-K · filed 2011-02-18 |
| 2008-12-31 | $2.04B 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |